NovaQuest Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $5.43M | Sell |
216,038
-382,947
| -64% | -$9.63M | 10.01% | 2 |
|
|
2020
Q2 | $14.6M | Hold |
598,985
| – | – | 16.95% | 2 |
|
|
2020
Q1 | $8.87M | Sell |
598,985
-959,441
| -62% | -$14.2M | 25.26% | 2 |
|
|
2019
Q4 | $25.3M | Hold |
1,558,426
| – | – | 31.93% | 2 |
|
|
2019
Q3 | $20.3M | Hold |
1,558,426
| – | – | 52.86% | 1 |
|
|
2019
Q2 | $20.2M | Hold |
1,558,426
| – | – | 39.13% | 2 |
|
|
2019
Q1 | $24.6M | Hold |
1,558,426
| – | – | 22.85% | 2 |
|
|
2018
Q4 | $31.4M | Hold |
1,558,426
| – | – | 35.49% | 2 |
|
|
2018
Q3 | $38.7M | Hold |
1,558,426
| – | – | 55.11% | 1 |
|
|
2018
Q2 | $42.8M | Hold |
1,558,426
| – | – | 61.17% | 1 |
|
|
2018
Q1 | $48M | Sell |
1,558,426
-1,538,224
| -50% | -$47.4M | 65.5% | 1 |
|
|
2017
Q4 | $111M | Buy |
+3,096,650
| New | +$111M | 88.05% | 1 |
|